PP_1170x120_10-25-21

Teva Global Generic Medicines Group

Teva announces CEO succession for generics group

Teva announces CEO succession for generics group

JERUSALEM, Israel — Dipankar Bhattacharjee has been promoted to president and chief executive officer of the Global Generic Medicines Group at Teva Pharmaceutical Industries Ltd. The appointment is effective immediately. Bhattacharjee, who has served as president and CEO of Teva Generics Europe since April 2013, succeeds Sigurdur Olafsson, who will step down from his role